HomeCompareRAMMF vs DIVO

RAMMF vs DIVO: Dividend Comparison 2026

RAMMF yields 3636.36% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RAMMF wins by $2866463184412.31M in total portfolio value
10 years
RAMMF
RAMMF
● Live price
3636.36%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2866463184412.34M
Annual income
$2,719,355,147,267,598,000.00
Full RAMMF calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — RAMMF vs DIVO

📍 RAMMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRAMMFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RAMMF + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RAMMF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RAMMF
Annual income on $10K today (after 15% tax)
$309,090.91/yr
After 10yr DRIP, annual income (after tax)
$2,311,451,875,177,458,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, RAMMF beats the other by $2,311,451,875,177,457,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RAMMF + DIVO for your $10,000?

RAMMF: 50%DIVO: 50%
100% DIVO50/50100% RAMMF
Portfolio after 10yr
$1433231592206.19M
Annual income
$1,359,677,573,633,799,400.00/yr
Blended yield
94.87%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RAMMF buys
0
DIVO buys
0
No recent congressional trades found for RAMMF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRAMMFDIVO
Forward yield3636.36%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$2866463184412.34M$30.7K
Annual income after 10y$2,719,355,147,267,598,000.00$981.68
Total dividends collected$2856387447109.89M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RAMMF vs DIVO ($10,000, DRIP)

YearRAMMF PortfolioRAMMF Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$374,336$363,636.36$11,349$649.42+$363.0KRAMMF
2$13,122,252$12,721,711.59$12,833$688.83+$13.11MRAMMF
3$430,821,997$416,781,187.80$14,459$727.90+$430.81MRAMMF
4$13,249,309,769$12,788,330,232.42$16,238$766.49+$13249.29MRAMMF
5$381,734,397,300$367,557,635,846.92$18,179$804.47+$381734.38MRAMMF
6$10,305,595,787,232$9,897,139,982,121.38$20,293$841.71+$10305595.77MRAMMF
7$260,738,028,023,917$249,711,040,531,578.75$22,591$878.14+$260738028.00MRAMMF
8$6,183,518,404,581,653$5,904,528,714,596,061.00$25,087$913.65+$6183518404.56MRAMMF
9$137,484,146,864,247,860$130,867,782,171,345,470.00$27,791$948.18+$137484146864.22MRAMMF
10$2,866,463,184,412,343,000$2,719,355,147,267,598,000.00$30,718$981.68+$2866463184412.31MRAMMF

RAMMF vs DIVO: Complete Analysis 2026

RAMMFStock

RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. It offers Epifractán, a cannabinoid pharmaceutical drug; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.

Full RAMMF Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this RAMMF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RAMMF vs SCHDRAMMF vs JEPIRAMMF vs ORAMMF vs KORAMMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.